Dalton Pharma Services
Dalton Pharma Services is a leading contract service provider in the pharmaceutical and biotechnology industries, offering integrated drug discovery, development, and manufacturing services. With over 30 years of experience, they emphasize quality, speed, and flexibility, supporting clients from discovery through to small-scale cGMP manufacturing. They are FDA Inspected and Health Canada approved, providing services including custom chemical synthesis, API manufacturing, formulation development, sterile fill-finish, and more. Their mission is to develop and manufacture high-quality medicines efficiently, leveraging their expertise and state-of-the-art facilities in Toronto, Canada.
Industries
Nr. of Employees
medium (51-250)
Dalton Pharma Services
Products
Research compounds catalogue (building blocks, labelled compounds, metabolites, peptides)
Catalogue of research‑grade small molecules and related compounds for R&D use, including building blocks, labelled compounds, metabolites, impurities and peptides.
Research compounds catalogue (building blocks, labelled compounds, metabolites, peptides)
Catalogue of research‑grade small molecules and related compounds for R&D use, including building blocks, labelled compounds, metabolites, impurities and peptides.
Services
Aseptic and terminally sterilized fill–finish of liquid and powder parenteral dosage forms for clinical and small‑scale commercial supply, supported by in‑house sterile formulation and QC microbiology.
Development and GMP production of active pharmaceutical ingredients from grams to multi‑kilos, with GMP suites, process validation, and regulatory support for ICH Q7 and similar standards.
Process and analytical R&D for API route development, optimization, purification, DoE studies, polymorphism studies, and transfer into GMP manufacture.
Pre‑formulation and formulation development including solubility, excipient selection, dissolution, stability studies, lyophilized and liposomal formats, and scale‑up for clinical batches.
Method development and testing services including impurity characterization, stability testing, ICP‑MS, UPLC and extractables/leachables studies to support development and regulatory filings.
Custom synthesis of fine chemicals, heterocycles, research building blocks, and custom peptides for discovery and early development needs.
Aseptic and terminally sterilized fill–finish of liquid and powder parenteral dosage forms for clinical and small‑scale commercial supply, supported by in‑house sterile formulation and QC microbiology.
Development and GMP production of active pharmaceutical ingredients from grams to multi‑kilos, with GMP suites, process validation, and regulatory support for ICH Q7 and similar standards.
Process and analytical R&D for API route development, optimization, purification, DoE studies, polymorphism studies, and transfer into GMP manufacture.
Pre‑formulation and formulation development including solubility, excipient selection, dissolution, stability studies, lyophilized and liposomal formats, and scale‑up for clinical batches.
Method development and testing services including impurity characterization, stability testing, ICP‑MS, UPLC and extractables/leachables studies to support development and regulatory filings.
Custom synthesis of fine chemicals, heterocycles, research building blocks, and custom peptides for discovery and early development needs.
Expertise Areas
- cGMP manufacturing and sterile fill–finish
- API process development and synthesis
- Formulation development (sterile and non‑sterile)
- Analytical development and stability testing
Key Technologies
- Aseptic fill–finish (RABS/isolation)
- Automated vial filling with serialization
- Sterile powder filling
- Lyophilization (freeze‑drying) and cycle optimization
News & Updates
Arch Biopartners Inc. and Dalton Pharma Services completed GMP glass vial filling for cilastatin, a drug candidate for preventing acute kidney injury.
Dalton Pharma Services commissioned 3P innovation to design and build a fully automated high-speed aseptic powder filling line.
The expansion includes a new automated cGMP sterile filling line supporting vials, syringes, and cartridges.
Dalton received approval from Health Canada for its Cannabis Analytical Test Licence.
Diamond Therapeutics hires David Brown, PhD, to advance formulation of psilocybin by Dalton Pharma.
Cortalex™ CBD is available online through Medical Cannabis by Shoppers Inc., manufactured by Dalton.
Arch Biopartners Inc. and Dalton Pharma Services completed GMP glass vial filling for cilastatin, a drug candidate for preventing acute kidney injury.
Dalton Pharma Services commissioned 3P innovation to design and build a fully automated high-speed aseptic powder filling line.
The expansion includes a new automated cGMP sterile filling line supporting vials, syringes, and cartridges.
Dalton received approval from Health Canada for its Cannabis Analytical Test Licence.
Diamond Therapeutics hires David Brown, PhD, to advance formulation of psilocybin by Dalton Pharma.
Cortalex™ CBD is available online through Medical Cannabis by Shoppers Inc., manufactured by Dalton.